CIENCIAS BIOMÉDICAS
Departamento
![Foto de Conchita](/img/nophoto.png)
Conchita
Izquierdo
Publicacións nas que colabora con Conchita Izquierdo (21)
2023
-
Changes in Invasive Pneumococcal Disease in the Paediatric Population in the Second COVID-19 Pandemic Year
Vaccines, Vol. 11, Núm. 10
2022
-
Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain
Emerging Infectious Diseases, Vol. 28, Núm. 11, pp. 2321-2325
2021
-
Necrotizing pneumonia due to Streptococcus pneumoniae in children during the period of non-systematic use of PCV13 in Catalonia, Spain
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 10, pp. 486-492
-
Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13
Microbiology Spectrum, Vol. 9, Núm. 3
2020
-
Effect of antiviral treatment in older patients hospitalized with confirmed influenza
Antiviral Research, Vol. 178
-
Epidemiological, clinical, and microbiological characteristics of serotype-3 streptoccocus pneumoniae infection after a partial introduction of the 13-valent pneumococcal conjugate vaccine: A prospective observational study
Journal of Pediatric Infectious Diseases, Vol. 15, Núm. 4, pp. 169-175
-
Erratum for Hernández et al., "Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Epidemic and Nonepidemic Influenza Periods"
Journal of clinical microbiology
-
Failures of 13-valent conjugated pneumococcal vaccine in age-appropriately vaccinated children 2-59 months of age, Spain
Emerging Infectious Diseases, Vol. 26, Núm. 6, pp. 1147-1155
-
Impact of the 13-valent conjugated pneumococcal vaccine on the direct costs of invasive pneumococcal disease requiring hospital admission in children aged < 5 years: A prospective study
Vaccines, Vol. 8, Núm. 3, pp. 1-17
-
Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era
Epidemiology and Infection
-
Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain
PLoS ONE, Vol. 15, Núm. 2
2019
-
Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13-valent pneumococcal conjugate vaccine era
Pediatric Pulmonology, Vol. 54, Núm. 5, pp. 517-524
-
Invasive pneumococcal disease and influenza activity in a pediatric population: Impact of PCV13 vaccination in pandemic and nonpandemic influenza periods
Journal of Clinical Microbiology, Vol. 57, Núm. 8
2018
-
Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: A multicentre case-control study
CMAJ, Vol. 190, Núm. 1, pp. E3-E12
2017
-
Costs associated with influenza-related hospitalization in the elderly
Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 412-416
-
Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain
PLoS ONE, Vol. 12, Núm. 2
-
Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study
PLoS ONE, Vol. 12, Núm. 8
-
Factors associated with 30-day mortality in elderly inpatients with community acquired pneumonia during 2 influenza seasons
Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 450-455
-
The effectiveness of influenza vaccination in preventing hospitalisations of elderly individuals in two influenza seasons: A multicentre case–control study, Spain, 2013/14 and 2014/15
Eurosurveillance, Vol. 22, Núm. 34
2016
-
Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study
Human Vaccines and Immunotherapeutics, Vol. 12, Núm. 7, pp. 1891-1899